Skip to content

Neuronetics STIM Price / book

Price / book at other companies

LifeStance Health Group logo
LifeStance Health GroupLFST
1.7×-0.1×
LBR
LB Pharmaceuticals Inc Common StockLBRX
1.9×
Stereotaxis logo
StereotaxisSTXS
12.5×-40.1×
Neuropace, Inc. logo
Neuropace, Inc.NPCE
30.6×+14.1×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
3.9×-0.5×
ClearPoint Neuro logo
ClearPoint NeuroCLPT
14.3×-2.1×

Other financials

Income statement

See full
Revenue$34.5M+7.8%
Gross profit$16.2M+2.6%
Operating income-$9.0M+18.3%
Net income-$10.8M+14.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$13.2M-34.7%
Total debt$85.4M+3.5%
Total equity$13.3M-62.6%
Total assets$125.4M-11.7%

Cash flow

See full
Operating cash flow-$9.4M+44.6%
CapEx$197.0K-10.0%
Free cash flow-$9.6M+44.1%

Valuation

See full
Market cap$90.46M-59.6%
Enterprise value$162.64M-44.6%
P/S0.6×-1.4×

Profitability

See full
Gross margin48%-15.6pp
Operating margin-19.4%-6.9pp
Net margin-24.5%-8.7pp
FCF margin-9.4%-4.1pp

Returns & leverage

See full
Return on equity-152.4%-1.4pp
Debt / equity6.4×+4.1×
Current ratio1.7×-0.8×

Where this comes from

Calculated from Neuronetics’s reported figures.

Based on the most recent quarter.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuronetics's price / book?
Neuronetics (STIM) reported price / book of 7.6× in Q1 2026.
How has Neuronetics's price / book changed year-over-year?
Neuronetics's price / book increased by 12.4% year-over-year, from 6.7× to 7.6×.
What is the long-term trend for Neuronetics's price / book?
Over 5 years (2020 to 2025), Neuronetics's price / book has grown at a -18.1% compound annual growth rate (CAGR), from 11.5× to 4.2×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.